Izafe Group
0,202 SEK -2,88%Vær den første som følger denne virksomhed
iZafe Group is a Life Science company focused on the development and marketing of digital medical solutions. The company offers products such as Dosell, a pharmaceutical robot, and the SaaS solution Pilloxa, a connected dose bag. The products aim to reduce the risk of incorrect medication. The customers are private individuals, pharmaceutical companies and public and private healthcare providers in Sweden, the Nordics and globally. iZafe Group has its headquarters in Stockholm.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
IZAFE B
Daglig lav / høj pris
0,2 / 0,22
SEK
Markedsværdi
55,67 mio. SEK
Aktieomsætning
23,63 t SEK
Volumen
116 t
Finanskalender
Delårsrapport
01.11.2024
Årsrapport
14.02.2025
Større aktionærerKilde: Millistream Market Data AB
| Ejer | Kapital | Stemmer |
|---|---|---|
| Gästrike Nord Invest AB | 20,7 % | 20,3 % |
| Stefan Wård | 11,0 % | 10,8 % |
| Nordnet Pension | 5,4 % | 5,3 % |
| Junior Farma SL | 4,8 % | 4,7 % |
| Francesco Mazzotta | 3,7 % | 3,6 % |
| Helena Rönnqvist | 3,7 % | 3,6 % |
| Hovgården Invest AB | 3,7 % | 3,6 % |
| K4 Gruppen Aktiebolag | 3,5 % | 3,4 % |
| Eva Redhe | 2,5 % | 2,5 % |
| Avanza Pension | 2,5 % | 2,4 % |
ViserAlle indholdstyper
iZafe Group Q2 Interim Report, April-June 20234
iZafe Group secures loan of SEK 5.5 million and cancels previously issued warrants of series TO14B
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools